EAEnrica Abrigo

Enrica Abrigo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Enrica Abrigo has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Federica Chiale

    Neonatal Pathology and Neonatal Intensive Care Unit, Sant’Anna Hospital, City of Health and Science University Hospital of Turin, University of Turin, 10126 Turin, Italy

    1 shared publication
  • Gianpaolo Di Rosa

    Regina Margherita Children's Hospital, Department of Radiology, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy

    1 shared publication
  • Isabella Morra

    Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Department of Pathology, Turin, Italy

    1 shared publication
  • Licia Peruzzi

    Regina Margherita Children's Hospital, Nephrology Dialysis and Transplantation Unit, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy

    1 shared publication
  • Luca Lonati

    Regina Margherita Children's Hospital, Division of Pediatric General Surgery, AOU Città della Salute e della Scienza, University of Turin, Turin, Italy

    1 shared publication
  • Silvia Einaudi

    Regina Margherita Children's Hospital, Pediatric Endocrinology, AOU Citta della Salute e della Scienza, University of Turin, Turin, Italy

    1 shared publication

Latest Publications

  • Severe arterial hypertension and hyperandrogenism in a boy: a rare case of catecholamine- and β-HCG-secreting pheochromocytoma

    by Federica Chiale, Enrica Abrigo, Luca Lonati, Gianpaolo Di Rosa, Isabella Morra, Licia Peruzzi, Silvia Einaudi

    Background: Pheochromocytomas (PCCs) and paragangliomas (PGLs) are known to physicians as the “great mimickers” because of their variable presentation, especially in the pediatric population. Rarely, they co-secrete other hormones. Case presentation: An 11-year-old boy presented with severe hypertension (HTN) with cardiac target organ damage. Signs of genital and cutaneous androgenization were observed, but the gonadal volume was prepubertal (2 mL). Urine normetanephrine and norepinephrine levels were elevated. Increased beta-human chorionic gonadotropin (β-HCG) and pubertal testosterone values with suppressed values of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) suggested an androgenization secondary to HCG hyperproduction. Imaging revealed a right adrenal mass, suggestive for PCC. Histopathology confirmed a PCC with positive staining for β-HCG. Postoperative resolution of symptoms of β-HCG and catecholamine excess and normalization of hormonal levels confirmed the diagnosis. Conclusions: Ectopic hormone secretion from PCC is possible, even if rare. Signs and symptoms attributable to ectopic hormones should be investigated in PCC patients. To date, this is the first case of a β-HCG-secreting PCC.